30 July 2025 in Wiadomości Lekarskie
Aim: To evaluate the effectiveness of determining the fertile window in women with idiopathic infertility based on the results of crystallization of saliva samples obtained using the Ovul portable device with a mobile application by comparing them with the results of urine test strips and folliculometry data.Material and methods: The menstrual cycles of 42 women with idiopathic infertility were analyzed: Group I - 21 women who took drugs to induce ovulation, Group II - 21 women with natural menstrual and ovarian cycles. Ovulation was confirmed or excluded based on the results of the Ovul device, urine test strips, and folliculometry.Results: Although ovulation detection using the Ovul device and urine test strips has 100% specificity, the sensitivity of the device is 97.4%and the accuracy is 97.6% (if the positive result is ovulation or the fertile window), while for urine test strips the sensitivity is 94.9% and the accuracy is 95.2% if we consider a positive result not only to be the same as the day of ovulation according to folliculometry, but also a positive result within the next 72 hours (mainly 12-24).Conclusions: Ovulation detection using the Ovul device is a highly accurate, 100% specific and highly sensitive method that can be used at home, will optimize diagnostics, make it more convenient and cheaper for patients who want to get pregnant or, on the contrary, who are trying to avoid pregnancy.
28 March 2025 in UKRAINIAN JOURNAL OF PERINATOLOGY AND PEDIATRICS
Aim - evaluation of effectiveness of vaginal suppositories containing boric acid and centella asiatica (Centella asiatica) for treatment in recurrent vulvovaginal candidiasis (RVVC) on the basis of papillomavirus infection. Materials and methods. The effectiveness of vaginal suppositories containing boric acid and centella asiatica (Centella asiatica) in treatment of RVVC in patients with papillomavirus infection was carried out. The study included 38 patients of the "Nova Medical" medical center (Vasylkiv) with RVVC, who had 3-5 repeated VVC episodes during the last year, on the basis of papillomavirus infection (confirmed by PCR). All patients received vaginal suppositories in the treatment regimen during 14 days. Statistical analysis was performed using the SPSS Statistics software (Statistica 6.0). Differences at p<0.05 are considered statistically significant. Results. All patients before treatment had inflammatory changes of the vaginal and cervical epithelium with the confirmed candidal nature: minor reaction - 28.9%, moderate - 63.2% and severe - 7.9%. The data obtained after using vaginal suppositories containing boric acid and centella asiatica (Centella asiatica) demonstrate a significant reduction in hyperemia of the vulvovaginal zone - 84.2% and -10.5% - slight hyperemia after treatment and the disappearance of microcracks (p<0.05). The colposcopic features indicates a significant decrease in the severity of the inflammatory process of the vagina and exocervix - 86.8% (p<0.05). Microscopic examination indicates 100% presence of candidal infection before treatment versus 13.2% after treatment. (p<0.05). Conclusions. Vulvovaginal candidiasis occurs in 59.4% of patients with papillomavirus infection. Combination of boric acid and centella asiatica (Centella asiatica) shows significant effectiveness of treatment RVVC. Clinical recovery was a total of 89.4%. Microbiological recovery was 86.8%. (p<0.05). The occurrence of repeated relapses after treatment did not have statistical significance, 13.2% of asymptomatic carriers of candidal infection required an extension of course up to 8 weeks. The study was carried out in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the Сommittee on bioethics and deontology of these institutions. Informed consent of the patients was obtained for the study. No conflict of interests was declared by the authors.
28 September 2024 in UKRAINIAN JOURNAL OF PERINATOLOGY AND PEDIATRICS
Aim - to study the features of the clinical course of pregnancy and childbirth in women with uterine leiomyoma (LM) in order to improve the prevention of obstetric complications in these pregnant women. Materials and methods. A prospective study was conducted to analyze the characteristics of the course of pregnancy and childbirth in 112 pregnant women with uterine leiomyoma (main group, MG). The control group (CG) consisted of 45 pregnant women without uterine LM and without pregnancy complications. Statistical analysis of the obtained data was performed using the SPSS Statistics software. Differences at p<0.05 are considered statistically significant. Results. In the first half of pregnancy, retrochorionic haematoma was detected in 38 (33.9%) women in MG and 1 (2.2%) patient in CG; low placentation - in 6 (14.3%) and 1 (2.2%) woman, respectively; pulling pain in the lower abdomen and lower back - in 78 (69.6%) patients in MG, and slight bloody discharge from the genital tract - in 33 (29.5%) women in MG. In the second half of pregnancy, the threat of late spontaneous abortion was noted in 26 (23.2%) women in MG and 2 (4.4%) patients in CG; the threat of preterm birth - in 39 (34.8%) and 3 (6.7%) cases, respectively; placental insufficiency - in 27 (24.1%) and 2 (4.4%) patients, respectively; preterm birth - in 18 (16.1%) patients in MG; fetal distress in labour - in 12 (10.7%) women in MG and 2 (4.4%) patients in CG; moderate preeclampsia - in 24 (21.4%) and 4 (8.9%) women, respectively; severe preeclampsia - in 4 (3.5%) pregnant women in MG; fetal growth retardation syndrome - in 21 (18.7%) women in MG and 1 (2.2%) patient in CG; caesarean section - in 48 (42.9%) women in MG and 2 (4.4%) patients in CG. Conclusions. In women with LM, pregnancy is complicated by the threat of miscarriage of various terms, the threat of premature birth, placental insufficiency with FGR syndrome, preeclampsia, which causes a high rate of caesarean sections. The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of the participating institution. The informed consent of the patient was obtained for conducting the studies. No conflict of interests was declared by the authors.